Biosimilars: Current situation and future expectations

被引：1
|
作者：
Forno, Guillermina [1 ,2 ]
Orti, Eduardo [1 ,2 ]
机构：
[1] Zelltek SA, Res & Dev, Santa Fe, Argentina
[2] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, RA-3000 Santa Fe, Argentina
来源：
EUROPEAN JOURNAL OF RISK REGULATION | 2012年 / 3卷 / 02期
关键词：
D O I：
10.1017/Si867299XO0002063
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
引用
收藏
页码：213 / 218
页数：6
相关论文
共 50 条
  • [1] Current situation of oncology biosimilars in Japan
    Nagai, Sumimasa
    [J]. LANCET ONCOLOGY, 2021, 22 (03): : E82 - E82
  • [2] Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future
    Godman, Brian
    Wilcock, Michael
    Martin, Andrew
    Bryson, Scott
    Baumgaertel, Christoph
    Bochenek, Tomasz
    de Bruyn, Winne
    Brkicic, Ljiljana Sovic
    D'Agata, Marco
    Fogele, Antra
    Fuste, Anna Coma
    Fraeyman, Jessica
    Fuerst, Jurij
    Garuoliene, Kristina
    Herholz, Harald
    Hoffmann, Mikael
    Jayathissa, Sisira
    Kwon, Hye-Young
    Langner, Irene
    Kalaba, Marija
    Karlsson, Eva Andersen
    Laius, Ott
    Markovic-Pekovic, Vanda
    Magnusson, Einar
    McTaggart, Stuart
    Metcalfe, Scott
    Pedersen, Hanne Bak
    Piessnegger, Jutta
    Ringerud, Anne Marthe
    Selke, Gisbert W.
    Sermet, Catherine
    Schiffers, Krijn
    Skiold, Peter
    Slaby, Juraj
    Tomek, Dominik
    Viksna, Anita
    Vitry, Agnes
    Zara, Corinne
    Malmstrom, Rickard E.
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2015, 4 (03): : 125 - 135
  • [3] Objective response rate assessment in oncology: Current situation and future expectations
    Aykan, Nuri Faruk
    Ozatli, Tahsin
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2020, 11 (02): : 53 - 73
  • [4] Biosimilars in the European Union: current situation and challenges
    Wolff-Holz, Elena
    Weise, Martina
    [J]. BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2020, 63 (11) : 1365 - 1372
  • [5] Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations
    Tronel, Claire
    Largeau, Berenger
    Ribeiro, Maria Joao Santiago
    Guilloteau, Denis
    Dupont, Anne-Claire
    Arlicot, Nicolas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04):
  • [6] Biosimilars in oncology: current and future perspectives
    Aapro, Matti
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2013, 2 (02): : 91 - 93
  • [7] Biosimilars: Current perspectives and future implications
    Misra, Monika
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (01) : 12 - 14
  • [8] Biosimilars: current status and future directions
    Roger, Simon D.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (07) : 1011 - 1018
  • [9] Biosimilars: current reality, promising future?
    Agusti Escasany, Antonia
    Rodriguez Cumplido, Dolores
    [J]. MEDICINA CLINICA, 2015, 145 (01): : 18 - 20
  • [10] Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer
    Hara, Fumikata
    Tajima, Kentaro
    Tanabe, Kosuke
    [J]. FUTURE ONCOLOGY, 2019, 15 (12) : 1353 - 1361
12345